argenx SE reported $47.16M in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
AstraZeneca USD 32.24B 1.68B Jun/2026
Genmab DKK 148M 5M Jun/2025
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
GRIFOLS EUR 8.52B 1.15B Jun/2026
Hikma Pharmaceutical USD 1.6B 46M Dec/2025
Lakefront Biotherapeutics EUR 6.44M 480K Mar/2026
Qiagen NV USD 1.65B 165.82M Mar/2026
UCB EUR 3.03B 12M Dec/2024